Alejandro B. Balazs, Ph.D.
Affiliations: | Harvard University, Cambridge, MA, United States |
Area:
Engineering ImmunityWebsite:
http://balazslab.comGoogle:
"Alejandro Balazs"Mean distance: 9.26 | S | N | B | C | P |
Parents
Sign in to add mentor| Richard Mulligan | grad student | 2006 | Harvard | |
| (Purification and characterization of hematopoietic stem cells by microarray analysis.) | ||||
| David Baltimore | post-doc | 2007-2013 | Caltech | |
Children
Sign in to add trainee| Jacqueline M. Brady | grad student | 2015-2020 | Harvard |
| Allen Lin | grad student | 2015-2020 | Harvard |
| Adam D. Nitido | grad student | 2017-2022 | Harvard |
| Meredith Phelps | grad student | 2018-2022 | Harvard |
| Lok Raj Joshi | post-doc | Harvard Medical School | |
| Martin J. Deymier | post-doc | 2016-2018 | Harvard |
| Cailin E. Deal | post-doc | 2014-2019 | Harvard |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhang AM, Elmoursi A, DiGiacomo DV, et al. (2024) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency. The Journal of Allergy and Clinical Immunology. Global. 3: 100234 |
| Roederer AL, Cao Y, St Denis K, et al. (2024) Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity. Medrxiv : the Preprint Server For Health Sciences |
| Wamhoff EC, Ronsard L, Feldman J, et al. (2024) Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds. Nature Communications. 15: 795 |
| Joshi LR, Gálvez NMS, Ghosh S, et al. (2023) Delivery platforms for broadly neutralizing antibodies. Current Opinion in Hiv and Aids |
| Nugent C, Abul Y, White EM, et al. (2023) Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers. Vaccine |
| Luthuli B, Gounder K, Deymier MJ, et al. (2023) Generation and characterization of infectious molecular clones of transmitted/founder HIV-1 subtype C viruses. Virology. 583: 14-26 |
| Nugent C, Abul Y, White E, et al. (2023) Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers. Medrxiv : the Preprint Server For Health Sciences |
| Canaday DH, Oyebanji OA, White EM, et al. (2023) SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine - Ohio and Rhode Island, September-November 2022. Mmwr. Morbidity and Mortality Weekly Report. 72: 100-106 |
| Bartsch YC, Chen JW, Kang J, et al. (2022) BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children. Npj Vaccines. 7: 158 |
| Hauser BM, Feldman J, Sangesland M, et al. (2022) Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen design. Cell Reports. Medicine. 100834 |